The workplace project – putting learning into practice

We want our education to be impactful, transforming an individual's practice - and through that, the team or service they work within. Intermodule projects are a core part of the education we offer, providing an opportunity to reinforce learning, test new knowledge and skills and improve local services.

Attendees have free reign over their project which must meet a local need, and they present their work back to their peers at module two of the course, and the class chooses a winning project.

We believe that one of the best ways to learn something is from others who have already learned it. We'd encourage you to have a look through the extensive 'back catalogue' of previous projects to find one addressing a similar need to the one in your area, or to learn how others have overcome obstacles you might face.

'Workplace projects give a space for the MasterClass's challenging learning outcomes to change things at a grassroots level and then to keep changing them - and this is what makes a difference to people with Parkinson’s.’
Dr Peter Fletcher, academic director & founder of Parkinson's Academy


Spotlight projects


Siponimod use in Northern Ireland
By Conor Hughes, Clinical fellow, Royal Victoria Hospital
Empowering health visitors: maximizing SMA recognition, referral, and treatment outcomes through educational initiative
By Dr Ushma Patel. clinical fellow in paediatric neurology, University Hospitals of Leicester NHS Trust & Yvonne Julien, neuromuscular care advisor, University Hospitals of Leicester NHS Trust
Development of a frailty memory service
By Dr Michelle McCarthy, Consultant community geriatrician, Countess Of Chester Hospital NHS Foundation Trust

All projects


Showing 31-40 of 101 projects

Safety of Cladribine in people with MS treated in a district general hospital: Audit Report
By Dr Chamila Perera, Senior Clinical Fellow in Neurology, Bedford Hospital NHS Trust
Nabilone, a CB1 agonist, for managing multiple sclerosis symptoms
By Dr Filipa Serrazina, Neurology Resident, Barts Health NHS Trust
How Frequently Should Immunoglobulin Levels be Monitored in Patients with Multiple Sclerosis receiving Ocrelizumab?
By Dr Trisha Mukherjee, Neurology Specialist Registrar ST5, University College London Hospitals NHS Foundation Trust & Dr Cyrus Daruwalla, Neurology Specialist Registrar, Cambridge University Hospitals NHS Foundation Trust
Initiating a new Disease Modifying Treatment (DMT) into an existing service
By Sarah Hughes, Multiple Sclerosis Specialist Nurse, Torbay and South Devon NHS Foundation Trust
Reducing Delays to DMT Initiation via Homecare Prescriptions in Multiple Sclerosis
By Rebecca Harrison, Specialist Pharmacist for Neurology & Stroke Band 8, Royal United Hospitals Bath NHS Foundation Trust
Reducing treatment waiting times
By Lynn Bezance, MS Specialist Nurse, South Tees Hospitals NHS Foundation Trust
Education on anticholinergic prescribing
By Dr Nina Mohan, CT2 Psychiatry, NIMDTA: Southern Health and Social Care Trust
Setting up a Complex Disease Modifying Drug (DMD) Switching Clinic
By Aoife Shields, MS Principal Pharmacist, University College London Hospitals NHS Foundation Trust